LONDON (Thomson Financial) - Biofusion PLC said its spin-out company Asterion Ltd has appointed Kevin Bryett chairman and Raymond Barlow chief executive with immediate effect, replacing David Catton and Peter Grant respectively. The company, which commercialises intellectual property developed at universities, said Peter Grant will remain on Asterion's board as a non-executive director.
